Quick Answer
Caris Life Sciences, Inc. reported Net Income of -$68.09 million for fiscal year 2025.
Caris Life Sciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$68.09M | +75.8% |
| 2024 | -$281.89M | +17.4% |
| 2023 | -$341.42M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $24.32M | +135.9% | +133.9% |
| June 30, 2025 | -$71.79M | -8.5% | -6.0% |
| September 30, 2024 | -$67.73M | — | -2.3% |
| June 30, 2024 | -$66.19M | — | — |
- Caris Life Sciences, Inc. showed an increase of +75.8% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, Caris Life Sciences, Inc.’s net income has grown by 80.1% (from -$341.42 million to -$68.09 million).
- The most recent figure is from Caris Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: